Oligodendroglioma
Related Products
Olig2 Recombinant Rabbit Monoclonal Antibody
Olig2, a basic helix–loop–helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuroepithelial tumors, ependymomas, subependymomas, medulloblastomas, and nonneuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid/rhabdoid tumor, and haemangioblastomas.
Specifications
- Catalog No.
- BX50189
- Clone No.
- BP6167
- Application
- IHC-P
- Subcellular location
- Nucleus
- Control
- Oligodendroglioma
- Recommended method
- HIER
- Volume
- 100μl/vial, 1ml/vial
- Dilution
- 1:100-1:200
- Immunogen
- Synthetic peptide corresponding to residues in Human Olig2 was used as an immunogen.
Reference
1.Shou JW et al. Front Cell Neurosci 13:395 (2019).
2. Cho KHT et al. Sci Rep 10:6904 (2020).
Support Documents
Order
- E-mail : sales@biolynx.cn
